TWIST1 Regulates FOXM1/β‐Catenin to Promote the Growth, Migration, and Invasion of Ovarian Cancer Cells by Activating MFAP2
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Lingqin Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, …. Hauptthemen laut MEDLINE: Twist-Related Protein 1, Forkhead Box Protein M1, Ovarian Neoplasms, beta Catenin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: This study was supported by the Health Science and Technology Program of Zhejiang Province in 2022 (Grant 2022KY688)..
Abstract (Originalsprache)
TWIST1 is aberrantly expressed in ovarian cancer (OC). MFAP2 is a downstream target of TWIST1, and we previously found MFAP2 facilitated OC development by activating FOXM1/β‐catenin. We planned to investigate the mechanisms of TWIST1 in OC. GEPIA (a database for gene expression analysis) and UALCAN (a database containing comprehensive cancer transcriptome and clinical patient data) investigated TWIST1's connection to MFAP2 and patient survival in ovarian serous cystadenocarcinoma (OV). Human OC cells (A2780 and CAOV3) were transfected with si‐TWIST1, oe‐TWIST1, oe‐MFAP2, or si‐TWIST1 + oe‐MFAP2. Cellular apoptosis, viability, migration, and invasion were detected. TWIST1, MFAP2, FOXM1, and β‐catenin protein expressions were tested. Dual‐luciferase and ChIP‐qPCR validated the correlation between MFAP2 and TWIST1. Moreover, OC mice were established by injecting OC cells subcutaneously. The pathology, apoptosis, as well as Ki67, TWIST1, MFAP2, FOXM1, and β‐catenin protein levels of tumors were assessed. TWIST1 expression positively correlated with MFAP2 expression, but negatively related to patients' survival in OV. TWIST1 overexpression promoted malignant behaviors, and increased MFAP2, FOXM1, and β‐catenin protein levels for OC cells. TWIST1 knockdown exhibited the opposite trend. In vivo, TWIST1 knockdown disrupted tissue structure, induced apoptosis, decreased Ki67, TWIST1, MFAP2, FOXM1, and β‐catenin protein levels in tumor. Interestingly, MFAP2 overexpression reversed the effects of TWIST1 knockdown in vitro and in vivo. Additionally, dual‐luciferase and ChIP‐qPCR confirmed MFAP2 was a downstream target for TWIST1 in OC. TWIST1 regulated FOXM1/β‐catenin to promote the growth, migration, and invasion of OC cells by activating MFAP2, indicating that targeting TWIST1 may be effective for treating OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
- Department of Gynecologic Oncology, Taizhou Cancer Hospital, Wenling, Zhejiang, China.
- Department of Oncology, Taizhou Cancer Hospital, Wenling, Zhejiang, China.
Förderung
- This study was supported by the Health Science and Technology Program of Zhejiang Province in 2022 (Grant 2022KY688).
Zitieren
APA
Zhao, L., Song, Q., Zheng, C., Sun, W., & Chen, Y. (2025). TWIST1 Regulates FOXM1/β‐Catenin to Promote the Growth, Migration, and Invasion of Ovarian Cancer Cells by Activating MFAP2. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70140
Vancouver
Zhao L, Song Q, Zheng C, Sun W, Chen Y. TWIST1 Regulates FOXM1/β‐Catenin to Promote the Growth, Migration, and Invasion of Ovarian Cancer Cells by Activating MFAP2. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70140
BibTeX
@article{Zhao2025,
author = {Zhao, Lingqin and Song, Qian and Zheng, Chao and Sun, Wei and Chen, Yaqing},
title = {TWIST1 Regulates FOXM1/β‐Catenin to Promote the Growth, Migration, and Invasion of Ovarian Cancer Cells by Activating MFAP2},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70140}
}
EUVIMED